Type
Results for
"[search-keyword]"
Sponsor content
253 result(s) found, displaying 1 to 10
- TBC Abbvie Pty LtdAug-2023Prescription medicine evaluationActive ingredient: Botulinim toxin type a.
- RINVOQ (Abbvie Pty Ltd)Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
- AusPAR: RINVOQAustralian Public Assessment Report (AusPAR)AusPAR for RINVOQ (Upadacitinib) for treatment of atopic dermatitis in patients aged 12 years and above.
- AusPAR: MaviretAustralian Public Assessment Report (AusPAR)AusPAR for Maviret (glecaprevir /pibrentasvir) for the treatment of adult and paediatric patients with chronic hepatitis C virus.
- RINVOQ (Abbvie Pty Ltd)Prescription medicine registrationActive ingredients: upadacitinib hemihydrate.
- SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial (375984)ARTGAustralian Register of Therapeutic Goods (ARTG) information for SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial.